Investment Rating - The investment rating for the company is "Buy-A" with a target price of 103.02 CNY per share, maintaining the rating [6]. Core Viewpoints - The company has achieved significant revenue growth driven by technological breakthroughs and accelerated domestic substitution demand, leading to an expansion of its customer base and order volume. Although the company has not yet turned a profit, the loss margin has narrowed significantly year-on-year [2][9]. - The company has increased its R&D investment and implemented equity incentives, which have led to higher share-based payment expenses, putting some pressure on short-term profits. The overall gross margin for H1 2025 was 54.31%, an increase of 8.08 percentage points year-on-year [2][9]. - The company has successfully mass-produced seven major devices and has established a complete yield management solution with nine series of equipment and three series of software, meeting the needs of leading domestic customers [3][4]. Financial Performance Summary - In H1 2025, the company achieved operating revenue of 702 million CNY, a year-on-year increase of 51.39%. The net profit attributable to the parent company was a loss of 18 million CNY, a year-on-year reduction in loss of 73.01% [1][2]. - For Q2 2025, the company reported operating revenue of 408 million CNY, a year-on-year increase of 78.73%, with a net profit loss of 3 million CNY, a year-on-year reduction in loss of 96.68% [1][2]. - The company expects revenues of 2.071 billion CNY, 3.023 billion CNY, and 4.202 billion CNY for the years 2025, 2026, and 2027, respectively, with net profits of 249 million CNY, 453 million CNY, and 636 million CNY for the same years [9][11].

Macro Analysis - The current market is influenced by three main macro variables: domestic demand recovery, policy implementation effects, and external environment changes[9] - The easing of US-China tariff negotiations helps alleviate market risk appetite pressures, but the long-term relationship remains competitive[9] - The economy is undergoing an L-shaped recovery, with manageable short-term pressures on foreign trade and employment, while low inflation remains a core challenge[9] Investment Recommendations - Strategic focus on Hong Kong stocks is advised, as de-dollarization benefits liquidity-sensitive markets[10] - A-shares are expected to experience high volatility, emphasizing the need to capture structural opportunities[10] - Suggested asset allocation includes resilient dividend assets in finance, resource sectors, and public utilities, with technology remaining a key focus[10] Company Highlights - Excellence New Energy (688196.SH) is a leader in biodiesel production, with a capacity of approximately 500,000 tons and a focus on raw material substitution[12] - Yipuli (002096.SZ) achieved revenue of 8.546 billion yuan in 2024, a 1.4% increase, with net profit rising by 12.49% to 713 million yuan[17] - Zijin Mining (601899.SH) expects copper production to reach 1.15 million tons in 2025, with gold production projected at 85 tons[24] Risk Factors - Potential risks include policy support falling short of expectations, execution delays, and slower-than-expected economic recovery[5] - For Excellence New Energy, risks involve trade barriers and raw material price fluctuations impacting profitability[16] - For Yipuli, risks include raw material price volatility and project execution delays affecting revenue growth[21]

25Q1收入同比稳健增长，毛利率同环比提升明显，费用短期影响利润表现。 25Q1收入2.94亿元，同比 +24.9%/环比-48.2%；毛利率58.1%，同比+3.7pcts/环比+7.5pcts；归母净利润亏损0.15亿元，同比减少 0.5亿元/环比减少0.55亿元；扣非净利润亏损0.43亿元，同比减少0.5亿元/环比减少0.4亿元。公司加速新 品研发和产品向更先进制程工艺迭代，股权激励费用、职工薪酬、研发投入等同比均有较大幅增长，而 一季度收入由于季节性影响基数较低，导致公司利润短期仍承压。 2024全年检量测设备收入同比均高增长，量测设备毛利率稳步提升。 公司整体收入和订单规模均快速 增长，2024年检测设备收入9.85亿元，同比+50.5%，销售机台176台，同比+53%，毛利率52.52%，同比 +0.28pct；量测设备收入3.61亿元，同比+62.9%，销售机台106台，同比+37.7%，毛利率37.5%，同比 +3.68pcts。 暗场设备出货量快速增长，明场设备验证进展顺利，关键尺寸设备实现对国内主流客户销售。1）无图 形晶圆缺陷检测设备： 公司订单量稳步增长，灵敏度更高的新一代产品通过多家 ...

风险高、业绩不稳定、退市风险高等特点，投资者面临较大的市场风险。投 资者应充分了解科创板市场的投资风险及本公司所披露的风险因素，审慎作 出投资决定。 Skyverse Technology Co., Ltd. （深圳市龙华区观澜街道新澜社区观光路 1301-14 号 101、102） 首次公开发行股票并在科创板上市 招股说明书 （注册稿） 本公司的发行申请尚需经上海证券交易所和中国证监会履行相应程 序。本招股说明书不具有据以发行股票的法律效力，仅供预先披露之用。 投资者应当以正式公告的招股说明书作为投资决定的依据。 中国证监会、上海证券交易所对本次发行所作的任何决定或意见，均不表 明其对发行人注册申请文件及所披露信息的真实性、准确性、完整性作出保证， 也不表明其对发行人的盈利能力、投资价值或者对投资者的收益作出实质性判 断或保证。任何与之相反的声明均属虚假不实陈述。 根据《证券法》的规定，股票依法发行后，发行人经营与收益的变化，由 发行人自行负责；投资者自主判断发行人的投资价值，自主作出投资决策，自 行承担股票依法发行后因发行人经营与收益变化或者股票价格变动引致的投资 风险。 发行人及全体董事、监事、高级管理 ...